17
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Clinical Study of T1a Glottic-type Cancer

, , , , , & show all
Pages 67-71 | Published online: 08 Jul 2009

References

  • Takahashi H, Furukawa K. Combination ra-diochemotherapy by tegafur or cisplatin in treatment of laryngeal cancer. Larynx Jpn 1990; 2: 193–7.
  • Ohmura M, Yamamoto E, Mizukami C, et al. Com-bined therapy of CO2 laser and irradiation for Ti, T2 laryngeal cancer. J Jpn Bronchoesophagol Soc 1992; 43: 471–4.
  • Hirano M, Hirade Y, Kawasaki H, et al. Phonatory function following laser surgery for glottic Tla car-cinomas. J Otolaryngol Jpn 1983; 86: 416–20.
  • Nakayama M, Takahashi H, Okamoto M, Yao K, Makoshi T, Nishiyama K. A clinico-pathologic re-view of recurrent patterns of the radiated early stage laryngeal cancer. Head Neck Cancer 1996; 22: 131–4.
  • Brundenburg JH, Condon KG, Frank TW. Coronal sections of larynges from radiation-therapy failures: a clinical-pathologic study. Otolaryngol Head Neck Surg 1986; 95: 213–8.
  • Takahashi H. Radiotherapy and radiochemotherapy for T3 and T4 carcinoma of larynx. Pract Otol 1994; 87: 1309–19.
  • Mori K, Umeno H, Chijiwa K, et al. Conservation treatment for Ti-T2 carcinoma of the larynx. Larynx Jpn 1999; 11: 47–52.
  • Tanabe T, Nakanoboh M, Kohno N, et al. The role of laser surgery for early laryngeal carcinoma. Larynx Jpn 1999; 11: 53–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.